Literature DB >> 26845138

Synthesis of Combretastatin A-4 Analogs and their Biological Activities.

Agnieszka Siebert, Monika Gensicka, Grzegorz Cholewinski, Krystyna Dzierzbicka1.   

Abstract

Combretastatin A-4 (CA-4) is a natural product, which consists of two phenyl rings, linked by an ethylene bridge. CA-4, inhibitor of polymerization of tubulin to microtubules, possesses a strong antitumor and anti-vascular properties both in vitro and in vivo. Previous studies showed that disodium phosphate salt of CA-4, a water-soluble prodrug is well tolerated at therapeutically useful doses. However, it should be noted that the cis-configuration of the double bond and the 3,4,5-trimethoxy group on ring A is necessary for the biological activity of CA-4. Structure of CA-4 renders the compound readily susceptible to isomerization, which reduces the potency and bioavailability. To circumvent this problem, a lot of scientists in the world synthesized a series of cis-restricted CA-4 analogs, where the double bond has been replaced by introduction of non-heterocyclic groups or heterocyclic groups like β -lactam and oxadiazole. This paper reviews the most important approaches in analogs of combretastatin synthesis and presents structure-reactivity relationships for these compounds. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CA-4; Cancer therapy; Combretastatin A-4; Inhibitors of angiogenesis; Synthesis; Biological activity

Year:  2016        PMID: 26845138     DOI: 10.2174/1871520616666160204111832

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  5 in total

1.  Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.

Authors:  Leilei Huang; Jinwen Huang; Hui Nie; Yingzi Li; Lixing Song; Fanhong Wu
Journal:  RSC Med Chem       Date:  2021-06-23

2.  Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents.

Authors:  Farida Tripodi; Federico Dapiaggi; Fulvia Orsini; Roberto Pagliarin; Guido Sello; Paola Coccetti
Journal:  Medchemcomm       Date:  2018-04-04       Impact factor: 3.597

3.  Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.

Authors:  Hongjun Yuan; Xin Li; Jing Tang; Min Zhou; Fengyong Liu
Journal:  Cancer Imaging       Date:  2019-11-04       Impact factor: 3.909

Review 4.  Cyclobutanes in Small-Molecule Drug Candidates.

Authors:  Marnix R van der Kolk; Mathilde A C H Janssen; Floris P J T Rutjes; Daniel Blanco-Ania
Journal:  ChemMedChem       Date:  2022-03-29       Impact factor: 3.540

5.  Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.

Authors:  Yong-Tao Duan; Ruo-Jun Man; Dan-Jie Tang; Yong-Fang Yao; Xiang-Xiang Tao; Chen Yu; Xin-Yi Liang; Jigar A Makawana; Mei-Juan Zou; Zhong-Chang Wang; Hai-Liang Zhu
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.